T. Rowe Price Associates’s LanzaTech LNZA Stock Holding History

T. Rowe Price Associates’s Portfolio LNZA Stock Details LNZA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-523	Closed	-$13K	–	3106
2025 Q1	$13K	Hold	523	–	–	﹤0.01%	3021
2024 Q4	$72K	Buy	523 +164	+46%	+$24.6K	﹤0.01%	2884
2024 Q3	$69K	Hold	359	–	–	﹤0.01%	2886
2024 Q2	$67K	Buy	+359	New	+$91.5K	﹤0.01%	2813

Other funds holding LNZA

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates's LNZA Position: Q2 2025 in Review

T. Rowe Price Associates sold out of LanzaTech (LNZA) in Q2 2025, closing a stake of 523 shares — an estimated $13K sold.

T. Rowe Price Associates first reported a position in LNZA in Q2 2024 and held it in 4 quarters. The position peaked at $72K in Q4 2024. 59 funds tracked by Wall St. Rank hold LNZA as of Q2 2025.

T. Rowe Price Associates reported no remaining LanzaTech position as of Q2 2025 after selling out during the quarter.
T. Rowe Price Associates sold 523 LanzaTech shares in Q2 2025, an estimated $13K.
T. Rowe Price Associates first reported a position in LanzaTech in Q2 2024 and held it in 4 quarters.
T. Rowe Price Associates's LanzaTech position peaked at $72K in Q4 2024.
59 funds tracked by Wall St. Rank held LanzaTech as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.